SKIN (SkinHealth Systems Inc. Class A Common Stock)
Insider Trading Activity
Every open-market purchase and sale reported by SKIN officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-12 | MICHAEL P. MONAHAN | Chief Financial Officer | F | — | — |
| 2026-04-13 | Sheri Lewis | CSO and COO | F | — | — |
| 2026-04-13 | MICHAEL P. MONAHAN | Chief Financial Officer | F | — | — |
| 2026-03-24 | Ronald Menezes | Chief Revenue Officer | A | — | — |
| 2026-03-24 | Pedro Bruno Ferreira Malha | President and CEO | A | — | — |
| 2026-03-24 | Sheri Lewis | CSO and COO | A | — | — |
| 2026-03-24 | MICHAEL P. MONAHAN | Chief Financial Officer | A | — | — |
| 2026-03-19 | Ronald Menezes | Chief Revenue Officer | F | — | — |
| 2026-03-19 | Sheri Lewis | CSO and COO | F | — | — |
| 2026-03-19 | MICHAEL P. MONAHAN | Chief Financial Officer | F | — | — |
| 2025-11-17 | PHILIPPE SCHAISON | Director | A | — | — |
| 2025-11-04 | Ronald Menezes | Chief Revenue Officer | F | — | — |
| 2025-10-10 | Pedro Bruno Ferreira Malha | President and CEO | A | — | — |
| 2025-08-12 | MICHAEL P. MONAHAN | Chief Financial Officer | F | — | — |
| 2025-06-18 | Doug K. Schillinger | Director | A | — | — |
| 2025-06-18 | STEPHEN J FANNING | Director | A | — | — |
| 2025-06-18 | Michelle C. Kerrick | Director | A | — | — |
| 2025-06-18 | Desiree Gruber | Director | A | — | — |
| 2025-06-18 | Brian Christopher Miller | Director | A | — | — |
| 2025-06-18 | BRENT L SAUNDERS | Director | A | — | — |
| 2025-06-03 | MICHAEL P. MONAHAN | Chief Financial Officer | F | — | — |
| 2025-04-11 | MICHAEL P. MONAHAN | Chief Financial Officer | F | — | — |
| 2025-04-11 | MARLA MALCOLM BECK | President and CEO | F | — | — |
| 2025-04-11 | Sheri Lewis | CSO and COO | F | — | — |
| 2025-03-19 | MICHAEL P. MONAHAN | Chief Financial Officer | A | — | — |
| 2025-03-19 | Ronald Menezes | Chief Revenue Officer | A | — | — |
| 2025-03-19 | MARLA MALCOLM BECK | President and CEO | A | — | — |
| 2025-03-19 | Sheri Lewis | CSO and COO | A | — | — |
| 2024-12-03 | MICHAEL P. MONAHAN | Chief Financial Officer | F | — | — |
| 2024-11-21 | Desiree Gruber | Director | Sell | — | — |
| 2024-08-13 | MICHAEL P. MONAHAN | Chief Financial Officer | F | — | — |
| 2024-08-13 | BRENT L SAUNDERS | Director | Buy | — | — |
| 2024-07-10 | Desiree Gruber | Director | A | — | — |
| 2024-07-10 | Michelle C. Kerrick | Director | A | — | — |
| 2024-07-10 | MICHAEL D CAPELLAS | Director | A | — | — |
| 2024-07-10 | Doug K. Schillinger | Director | A | — | — |
| 2024-07-10 | Brian Christopher Miller | Director | A | — | — |
| 2024-07-10 | Julius Few | Director | A | — | — |
| 2024-07-10 | BRENT L SAUNDERS | Director | MIXED | — | — |
| 2024-06-11 | Daniel Copell Watson | Chief Revenue Oficer | F | — | — |
| 2024-06-11 | MARLA MALCOLM BECK | President and CEO | F | — | — |
| 2024-04-11 | Daniel Copell Watson | Chief Revenue Oficer | A | — | — |
| 2024-04-11 | MARLA MALCOLM BECK | President and CEO | A | — | — |
| 2024-04-11 | MICHAEL P. MONAHAN | Chief Financial Officer | A | — | — |
| 2023-12-01 | MICHAEL P. MONAHAN | Chief Financial Officer | A | — | — |
| 2023-12-01 | Bradley Hauser | Chief Operating Officer | A | — | — |
| 2023-12-01 | Daniel Copell Watson | Chief Revenue Oficer | A | — | — |
| 2023-11-21 | MARLA MALCOLM BECK | Interim CEO | A | — | — |
| 2023-08-21 | Brian Christopher Miller | Director | Buy | — | — |
| 2023-08-18 | Julius Few | Director | Buy | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | 10%+ Owner | 36,568,002 | — |
| — | 10%+ Owner | 33,360,741 | — |
| — | Director | 7,676,591 | — |
| — | President and CEO | 4,845,251 | — |
| — | President and CEO | 2,753,401 | — |
| — | Chief Executive Officer | 2,470,174 | — |
| — | Chief Financial Officer | 1,955,280 | — |
| — | Chief Revenue Officer | 1,759,915 | — |
| — | CSO and COO | 1,584,620 | — |
| — | Chief Revenue Oficer | 789,324 | — |
| — | Chief Executive Officer | 702,933 | — |
| — | Chief Financial Officer | 591,388 | — |
| — | Director | 527,283 | — |
| — | Chief Operating Officer | 390,632 | — |
| — | Director | 276,146 | — |
| — | Director | 243,035 | — |
| — | Director | 216,035 | — |
| — | Director | 194,341 | — |
| — | Director | 192,565 | — |
| — | Director | 189,813 | — |
| — | President, APAC | 66,716 | — |
| — | Director | 57,692 | — |
| — | President, EMEA | 55,596 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the SKIN quote page; the site-wide leaderboard is on the insider transactions hub.